Continuous Glucose Monitors
Insulin Pumps & Supplies
Diabetes Testing Supplies
Blood Glucose Meters
Smart Insulin Pens
Insulin Vials
View All
CeQur Simplicity Insulin Patch
CeQur Simplicity is an innovative, FDA-cleared solution for easy diabetes management. Designed for 4-day wear, this bolus-only insulin patch eliminates the need for multiple daily injections and delivers U-100 insulin in precise 2-unit clicks. CeQur Simplicity’s on-demand dosing requires no programming or digital setup, making it easy to use. The flexible cannula ensures comfortable wear, while the thin, lightweight design stays discreet under clothing.
Secure during exercise, bathing, and swimming, CeQur Simplicity fits seamlessly into your daily routine. It's clinically proven to improve adherence, time in range, and A1C levels for an enhanced quality of life without the hassle of frequent injections.†,‡
- Delivers a 2-unit dose with every squeeze of the buttons
- Holds up to 200 units of rapid-acting insulin
- For mealtime and bolus correction use with U-100 insulins: Humalog® or NovoLog®§
- Clinically tested to reduce A1C by 1.7%† and improve time-in-range by 50% after 24 weeks‡
- Low profile and soft corners ensure added comfort
- Water-resistant design stays secure
- Small, flexible cannula provides swift insulin delivery
- Audible click offers dose confirmation
CeQur Simplicity Insulin Patch Safety Features
Two button squeeze: You must completely squeeze both tan buttons on your patch to deliver insulin. Squeezing one button will not deliver any insulin.
Locked buttons: If the patch runs out of insulin or the cannula is blocked, the tan buttons lock in the “squeezed” position and no click is heard.
If at any time the buttons lock:
1. Remove and place a new patch at a new site.
2. Continue with your current bolus dosing and give the remainder of that dose.
Example: You want to dose 8 units and the tan buttons lock after 4 units. Just replace the patch and continue with the rest of the dose.
3. It is important to check your blood glucose 1 to 2 hours after replacement. This is because the last squeeze of the patch you just removed may have short-dosed when the tan buttons locked, and the first squeeze of a new patch is 0.3 units short.
What is CeQur Simplicity?
CeQur Simplicity is a 4-day wearable insulin patch that delivers rapid-acting insulin for mealtime and correction boluses.
How to Write a Prescription for CeQur Simplicity
Providers may prescribe CeQur Simplicity through their preferred method. ADS accepts prescriptions via EMR, email, or fax.
What are the CeQur Simplicity prescription instructions?
1. Prescribe CeQur Simplicity 2U patch, 8-pack
2. Prescribe CeQur Simplicity Inserter
3. Prescribe a vial of rapid-acting insulin – labeled for use with Humalog® U-100 or Novolog® U-10043
4. Ensure patients schedule their training session to get started. Training must occur prior to first usage. A healthcare provider from your office or a member of the CeQur Cares clinical team can train the patient. Have patients contact CeQur Cares Team at 1-888-552-3787 or [email protected].**
How much is CeQur Simplicity?
CeQur Simplicity is covered as a pharmacy benefit by a majority of both Commercial and Medicare Part D plans. Patient co-pay and/or co-insurance will vary based on the individual patient’s benefit design.
For eligible patients whose insurance does not cover CeQur Simplicity or have a high copay, the CeQur Simplicity CoPay Savings Program may help. Learn more at CeQur Simplicity Copay Savings.
Can children use CeQur Simplicity?
No. CeQur Simplicity is labeled for use in adults over the age of 21 who have been diagnosed with type 1 or type 2 diabetes.
When using products sold by Advanced Diabetes Supply, always refer to the directions provided by the product’s manufacturer for usage information. Click here to find the CeQur Simplicity User Manual.
†1Bergenstal R, Peyrot M, Dreon D, Aroda V, Bailey T, Brazg R, Frias J, Johnson M, Klonoff D, Kruger D, Ramtoola S, Rosenstock J, Serusclat P, Weinstock R, Naik R, Shearer D, Zraick V, Levy B on behalf of the Calibra Study Group. 2019. Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. Diabetes Technology and Therapeutics 21 (5):1-13.
‡Bergenstal RM, Johnson ML, Aroda VR, et al. Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles. J Diabetes Sci Technol. 2022;16(5):1167-1173.
§Humalog is a registered trademark of Eli Lilly and Company. Novolog is a registered trademark of Novo Nordisk A/S.
**https://myceqursimplicity.com/healthcare-professionals/
